References
- 1. Lisnevskaia L, Murphy G, Isenberg DA. Systemic lupus erythematosus. Lancet. 2014;384:1878–1888. doi:10.1016/S0140-6736(14)60128-8 (PubMed)
- 2. Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365: 2110-2121; Lisnevskaia L, Murphy G, Isenberg D: Systemic lupus erythematosus. Lancet (2014) 384: 1878-1888; Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: a critical review. Autoimmun Rev (2012) 12: 174-194.
- 3. Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. doi:10.3389/fimmu.2018.02279 (PubMed)
- 4. Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology. 2009;48:673–675. (PubMed)
- 5. Chambers SA, Rahman A, Isenberg DA: Treatment adherence and clinical outcome in systemic lupus Erythematosus. Rheumatology (2007) 46:895–898.
- 6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney int, (2013) Suppl 3:1–150.